申请人:Nielsen Mogens
公开号:US20110105553A1
公开(公告)日:2011-05-05
The present invention relates to novel GABA
A
/BzR ligands of the general formulas (I), (II) and (III) wherein R
1
is selected from the group consisting of hydrogen, halogen, haloalkyl having 1-2 carbon atoms, alkoxy having 1 to 3 carbon atoms in the alkyl chain, alkyl having 1 to 3 carbon atoms, and nitro, and R
2
is selected from the group consisting of hydrogen, halogen and alkyl having 1 to 2 carbon atoms, as well as the use of these compounds for treating anxiolytic, anticonvulsant, sedative-hypnotic and myorelaxant conditions as well as anxiogenic, somnolytic and convulsant conditions in mammals including pharmaceutical compositions comprising the same
本发明涉及一种新型GABAA/BzR配体,其通式为(I)、(II)和(III),其中R1选自氢、卤素、具有1-2个碳原子的卤代烷基、具有1-3个碳原子的烷氧基、具有1-3个碳原子的烷基和硝基的群体,R2选自氢、卤素和具有1-2个碳原子的烷基的群体,以及使用这些化合物治疗哺乳动物的抗焦虑、抗惊厥、镇静催眠和肌松作用症状,以及包括这些化合物的制药组合物。